EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Baudax Bio's enterprise value is $8.17 Mil.
Baudax Bio's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $1.27 Mil. Therefore, Baudax Bio's EV-to-Revenue for today is 6.44.
The historical rank and industry rank for Baudax Bio's EV-to-Revenue or its related term are showing as below:
BXRXQ'
s EV-to-Revenue Range Over the Past 10 Years
Min: -3.11 Med: 9.47 Max: 146.86
Current: 6.44
During the past 6 years, the highest EV-to-Revenue of Baudax Bio was 146.86. The lowest was -3.11. And the median was 9.47.
BXRXQ's EV-to-Revenue is ranked better than 54.64% of 1034
companies
in the Biotechnology industry
Industry Median: 7.775
vs BXRXQ: 6.44
As of today (2024-04-30), Baudax Bio's stock price is $0.01.
Baudax Bio's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.78. Therefore, Baudax Bio's PS Ratio for today is 0.01.
Baudax Bio EV-to-Revenue Historical Data
The historical data trend for Baudax Bio's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Baudax Bio's EV-to-Revenue
For the Biotechnology subindustry, Baudax Bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baudax Bio's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Baudax Bio's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Baudax Bio's EV-to-Revenue falls into.
Baudax Bio's current Enterprise Value is $8.17 Mil.
Baudax Bio's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.27 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baudax Bio (OTCPK:BXRXQ) EV-to-Revenue Explanation
Baudax Bio's share price for today is $0.01.
Baudax Bio's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.78.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baudax Bio EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Baudax Bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BXRXQ has been successfully added to your 